Publications
A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India
M P Jadhav 1 , V M Shinde, S Chandrakala, F Jijina, H Menon, B Arora, P A Kurkure, P M Parikh, N A Kshirsagar Abstract
Background: In patients with persistent fever and netropenia, amphotericin B is administered empirically for early treatment and prevention of systemic fungal infections. Despite this treatment, there are chances of breakthrough fungal infections and drug is also toxic.
